Iprindole in depressive states: a controlled, double-blind study.
D000284:Administration, Oral; D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001799:Blood Sedimentation; D001806:Blood Urea Nitrogen; D002986:Clinical Trials as Topic; D004906:Erythrocyte Count; D004912:Erythrocytes; D006452:Hemoglobinometry; D006801:Humans; D007099:Imipramine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D007488:Iprindole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010352:Patient Dropouts; D011581:Psychological Tests; D013997:Time Factors
D000928:Antidepressive Agents; D007211:Indoles; D007488:Iprindole; D007099:Imipramine